Cor et Vasa, 2006 (vol. 48), issue 1

Redakční rada děkuje všem recenzentům

Cor Vasa 2006, 48(1):10 | DOI: 10.33678/cor.2006.007  

Editorial

Pohlednice z Prahy a pohled na nás

Michael Aschermann

Cor Vasa 2006, 48(1):8-9 | DOI: 10.33678/cor.2006.006  

Original research articles

In vivo Study of a Collagen Impregnated Polyester Arterial Prosthesis: the Arteknit Ra K® Graft

Peter Ondruš, Roman Alberty, Jacques Lamarche, Vincent Echavé, Jacques Poisson

Cor Vasa 2006, 48(1):12-18 | DOI: 10.33678/cor.2006.009  

Purpose:We have previously reported that a transient increase in intracellular Ca2+ concentrations in endothelial-like cells may reflect the endothelization process on the Arteknit Ra K® polyester arterial prosthesis implanted in the aorta of mongrel dogs (Physiol Res 51; 217-20:2002). In this study, we further examine early arterial graft healing, i. e. patency, morphology, endothelization and thromboresistance, after short implantation periods in these dogs. Methods:We implanted 12 Arteknit Ra K® prostheses in the aorta of mongrel dogs for scheduled periods ranging from 48 hours to 6 months. The explanted graft specimens...

The role of transesophageal echocardiography in assessing morphological and functional pulmo-nary vein parameters with an emphasis on detecting pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation.

Miloslav Dorda, Martin Fiala, Jaroslav Januška, Libor Škňouřil, Marian Branny

Cor Vasa 2006, 48(1):19-23 | DOI: 10.33678/cor.2006.010  

Aim:The aim of our study was to define the potential uses of transesophageal echocardiography in the diagnosis of functional and morphologic parameters of pulmonary veins with special emphasis on detecting pulmonary vein stenosis fol-lowing radiofrequency catheter ablation for atrial fibrillation using electroanatomically navigated circumscribed lesions with pulmonary vein isolation. Method:Using Doppler imaging before and one month after ablation for atrial fibrillation, the average diameter of pulmonary vein ostia and peak blood flow rates (Vmax) were compared in 66 patients (16 women) with a mean age of 54.6 ± 8...

Review articles

The benefits and pitfalls of evidence-based medicine

Jiří Widimský

Cor Vasa 2006, 48(1):24-31 | DOI: 10.33678/cor.2006.011  

A major benefit of evidence-based medicine is that it allows obtaining information about treatment, most difficult to get empirically. In addition, it provides information about the side effects of new drugs, not known at the time they were ap-proved for clinical practice.Cardiology is a specialty making the most of data of evidence-based medicine, that is, information derived from prospective, randomized, double-blind controlled trials focusing on hard" endpoints such as modulation of morbidity and mortality. Data emerging from costly prospective studies of morbidity and mortality substantially extend and improve our therapeutic options, while...

Letters

Vážená redakce

David Stejskal, Bořek Lašák

Cor Vasa 2006, 48(1):35-36 | DOI: 10.33678/cor.2006.013  

Images in cardiology

Koronární mikropíštěle ústící do levé komory

Marcela Škvařilová, Jan Bělohlávek, Tomáš Paleček, Stanislav Šimek, Jan Horák

Cor Vasa 2006, 48(1):11 | DOI: 10.33678/cor.2006.008  

Short communication

FIELD (Fenofibrate Intervention and Event Lowering in Diabetes)

Jindřich Špinar, Jiří Vítovec

Cor Vasa 2006, 48(1):32-34  

The FIELD study was presented at the American Heart Association (AHA) annual meeting held in Dallas, Texas, USA in November 2005 and published simultaneously in The Lancet. The study was designed to assess, in a total of 9,795 patients with diabetes, the effect of fenofibrate vs. placebo in individuals with normal or mildly increased cholesterol and triglycerides > 5 mmol/l. The study demonstrated a decrease in cardiovascular events (p = 0.035); this, however, was associated with a non-significant rise in total (p = 0.18) and cardiovascular mortality (p = 0.41). FIELD documented the safety of fibrate therapy with an incidence of side effects > 1.0%.

Kardio

Zamyšlení nad tradicemi české vývojové kardiologie

Cor Vasa 2006, 48(1):K2  

Doporučení pro diagnostiku a léčbu akutního srdečního selhání

Cor Vasa 2006, 48(1):K3  

K životnímu jubileu MUDr. Jiřího Endryse, CSc.

Cor Vasa 2006, 48(1):K32  

Kroky ke zdraví - kondiční program "Pro srdce Hané"

Cor Vasa 2006, 48(1):K33  

Kalendář odborných akcí

Cor Vasa 2006, 48(1):K34  


Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.